Review: Remdesivir improves recovery, reduces mortality of COVID-19 patients
15 Oct 2020
byStephen Padilla
A systematic review of randomized controlled trials (RCTs) has confirmed the potential of remdesivir in improving recovery and reducing serious adverse events (AEs), as well as mortality and time to clinical improvement, but not hospital length of stay, in coronavirus disease (COVID-19) patients.